BioSpace News Archive

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces the appointment of David Moskowitz to the newly created position of Vice President, Capital Markets Strategy & Investor Relations.

Mobidiag Ltd. announces that it has been granted EUR 1.5 million additional funding from Business Finland for the continued development of a rapid diagnostic test for sepsis using Mobidiag’s Novodiag platform.

IRRAS, a global healthcare company with a comprehensive portfolio of innovative solutions for neurocritical care, provides an update on the launch of its products in the United States and product portfolio objectives for 2020.

Beckman Coulter, a global leader in clinical diagnostics, announced that South West London Pathology has implemented DxH 900 haematology analysers and the Early Sepsis Indicator across the SWLP network.

Quality Executive Partners, Inc. (QxP) is honored to recognize the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) for their support during development of Virtuosi®, an on-demand educational platform that leverages the power of virtual reality (VR)

Opthea Limited, a clinical stage biopharmaceutical company developing novel biologic therapies to treat eye diseases, has completed patient recruitment into the Company’s Phase 2a trial evaluating the safety and efficacy of OPT-302 administered in combination with aflibercept for treatment of diabetic macular edema.

PhoreMost to deploy its SITESEEKER platform to identify novel targets for Boehringer Ingelheim’s discovery programmes

Amarin Corporation plc (NASDAQ:AMRN), today provided a business update, including an update of preliminary 2019 results and additional 2020 financial guidance

Intabio, Inc. announced a publication in Electrophoresis that provides the first in-depth description of Intabio’s Blaze imaged capillary isoelectric focusing – mass spectrometry system and its ability to quickly characterize and identify intact protein charge variants.

TriLink BioTechnologies announced that the United States Patent and Trademark Office has issued two new patents to the company.